• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: QUIDEL CORP. QUICKVUE AT-HOME OTC COVID-19 TEST; CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

QUIDEL CORP. QUICKVUE AT-HOME OTC COVID-19 TEST; CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM Back to Search Results
Lot Number N1J2201
Device Problem Inadequate Instructions for Non-Healthcare Professional (2956)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/31/2021
Event Type  malfunction  
Event Description
The product was the quidel quickvue at-home otc covid-19 test.The problem relates to package insert instructions for interpreting the test.Step 11 clearly states, "a negative result will show a blue line but no pink line." in other words, a test should be considered positive if there is a pink line.However this is not accurate.In the normal use of the test a pink line can appear and the test should be interpreted as negative as per the company's faqs that are published on their website.After searching the internet, i found the below "if i see pink shading on the strip bordering the black label, is this a positive result? only a pink line about half of a centimeter below the blue control line should be considered a positive result.A pink line bordering the black label with the arrows, a vertical pink line, or a faint grey line next to the blue control line is not considered a positive test line and should not be called a positive result." there is also a diagram showing the various lines and how to interpret.If not a design flaw, that at minimum, the package insert is misleading and needs to change.The information in the faqs should be in the package insert.There is no reference to this phenomenon in the package insert.A patient should not have to have access to, and search the internet for how to interpret this test.(b)(4).Fda safety report id # (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
QUICKVUE AT-HOME OTC COVID-19 TEST
Type of Device
CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM
Manufacturer (Section D)
QUIDEL CORP.
MDR Report Key13251031
MDR Text Key283845975
Report NumberMW5106618
Device Sequence Number1
Product Code QKP
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 01/10/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Expiration Date10/23/2023
Device Lot NumberN1J2201
Was Device Available for Evaluation? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received01/12/2022
Patient Sequence Number1
Patient Age65 YR
Patient SexMale
Patient Weight86 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-